| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.41 | 5e-28 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.4 | 2e-27 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-06 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |